Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment

Open Access

Peer-reviewed

Research Article

Thong Phe ,

* E-mail: thongphe@sihosp.org

Affiliation Department of Infectious Diseases, Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia
⨯
Sopheak Thai,

Affiliation Department of Infectious Diseases, Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia
⨯
Chhunheng Veng,

Affiliation Department of Infectious Diseases, Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia
⨯
Sopheak Sok,

Affiliation Department of Infectious Diseases, Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia
⨯
Lutgarde Lynen,

Affiliation Department of Clinical Sciences, Institute of Tropical Medicine (ITM), Antwerp, Belgium
⨯
Johan van Griensven

Affiliations Department of Infectious Diseases, Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia, Department of Clinical Sciences, Institute of Tropical Medicine (ITM), Antwerp, Belgium
⨯

Reader Comments (0)

Anemia
Is the Subject Area "Anemia" applicable to this article?

Thanks for your feedback.
Hemoglobin
Is the Subject Area "Hemoglobin" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Prophylaxis
Is the Subject Area "Prophylaxis" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.